Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP5204)
Name
Tanshinone I
Synonyms
Tanshinone I; 568-73-0; Tanshinone A; Tanshinon I; Tanshinone; 1,6-Dimethylphenanthro[1,2-b]furan-10,11-dione; Tanshinone-I; UNII-03UUH3J385; C18H12O3; 1,6-dimethylnaphtho[1,2-g][1]benzofuran-10,11-dione; MLS000697676; 03UUH3J385; 1,6-Dimethyl-phenanthro[1,2-b]furan-10,11-dione; 1,6-dimethylnaphtho[1,2-g]benzofuran-10,11-dione; MFCD00210563; Phenanthro[1,2-b]furan-10,11-dione, 1,6-dimethyl-; SMR000445578; 1,6-Dimethylphenanthro(1,2-b)furan-10,11-dione; Phenanthro(1,2-b)furan-10,11-dione, 1,6-Dimethyl-; Tanshinquinone I; Tanshinone I,(S); TRISTEARYLORTHOFORMATE; MLS006011773; SCHEMBL244391; CHEMBL363535; cid_114917; AIGAZQPHXLWMOJ-UHFFFAOYSA-; BDBM51317; DTXSID90972247; Tanshinone I, analytical standard; CHEBI:149906; HMS2222J14; HMS3656A11; Tanshinone I, >=98% (HPLC); BCP28292; HY-N0134; ZINC2558154; BBL010133; s2364; STK801472; AKOS005613012; AC-7999; CCG-267206; MCULE-4980744982; NCGC00247624-01; NCGC00247624-02; NCGC00247624-03; NCGC00247624-05; AK168189; AS-68049; DB-052982; FT-0632407; N1845; SW219821-1; V1541; 568T730; A831218; Q-100655; 1,6-dimethylnaphtho[1,2-g]benzofuran-10,11-quinone; 1,6-Dimethylphenanthro[1,2-b]furan-10,11-dione #; Q27247588; 1,6-dimethyl-10H,11H-phenanthro[1,2-b]furan-10,11-dione
    Click to Show/Hide
Species Origin Salvia miltiorrhiza ...     Click to Show/Hide
Salvia miltiorrhiza
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Lamiales
Family: Lamiaceae
Genus: Salvia
Species: Salvia miltiorrhiza
Disease Ovarian cancer [ICD-11: 2C73] Investigative [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C18H12O3
PubChem CID
114917
Canonical SMILES
CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C4=C3OC=C4C
InChI
1S/C18H12O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-8H,1-2H3
InChIKey
AIGAZQPHXLWMOJ-UHFFFAOYSA-N
CAS Number
CAS 568-73-0
ChEBI ID
CHEBI:149906
Herb ID
HBIN045505
SymMap ID
SMIT00260
TCMSP ID
MOL007157
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Lenalidomide      Multiple myeloma     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression ACD  Molecule Info 
Pathway MAP
Down-regulation Expression TERF2IP  Molecule Info 
Pathway MAP
Down-regulation Expression TNKS-1  Molecule Info 
Pathway MAP
                    In-vitro Model RPMI-8226 CVCL_0014 Plasma cell myeloma Homo sapiens
U266B1 CVCL_0566 Plasma cell myeloma Homo sapiens
                    Experimental
                    Result(s)
Combination of TanI with standard chemotherapeutic drug Len, potentiates cell death in myeloma cells.
References
Reference 1 Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Prolif. 2020 Feb;53(2):e12739.
Reference 2 Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules. Mol Biol Rep. 2018 Dec;45(6):2429-2439.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China